These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27043998)

  • 21. Target Selectivity of FimH Antagonists.
    Scharenberg M; Schwardt O; Rabbani S; Ernst B
    J Med Chem; 2012 Nov; 55(22):9810-6. PubMed ID: 23088608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.
    Bouckaert J; Mackenzie J; de Paz JL; Chipwaza B; Choudhury D; Zavialov A; Mannerstedt K; Anderson J; Piérard D; Wyns L; Seeberger PH; Oscarson S; De Greve H; Knight SD
    Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence.
    Schembri MA; Klemm P
    Infect Immun; 2001 Mar; 69(3):1322-8. PubMed ID: 11179294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and adhesive properties of the long polar fimbriae protein LpfD from adherent-invasive Escherichia coli.
    Coppens F; Iyyathurai J; Ruer S; Fioravanti A; Taganna J; Vereecke L; De Greve H; Remaut H
    Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1615-26. PubMed ID: 26249343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands.
    Sperling O; Fuchs A; Lindhorst TK
    Org Biomol Chem; 2006 Nov; 4(21):3913-22. PubMed ID: 17047870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation.
    Klein T; Abgottspon D; Wittwer M; Rabbani S; Herold J; Jiang X; Kleeb S; Lüthi C; Scharenberg M; Bezençon J; Gubler E; Pang L; Smiesko M; Cutting B; Schwardt O; Ernst B
    J Med Chem; 2010 Dec; 53(24):8627-41. PubMed ID: 21105658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.
    Chevalier G; Laveissière A; Desachy G; Barnich N; Sivignon A; Maresca M; Nicoletti C; Di Pasquale E; Martinez-Medina M; Simpson KW; Yajnik V; Sokol H; ; Plassais J; Strozzi F; Cervino A; Morra R; Bonny C
    Microbiome; 2021 Aug; 9(1):176. PubMed ID: 34425887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors.
    Sattigeri JA; Garg M; Bhateja P; Soni A; Rauf ARA; Gupta M; Deshmukh MS; Jain T; Alekar N; Barman TK; Jha P; Chaira T; Bambal RB; Upadhyay DJ; Nishi T
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2993-2997. PubMed ID: 30017316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an aggregation assay to screen FimH antagonists.
    Abgottspon D; Rölli G; Hosch L; Steinhuber A; Jiang X; Schwardt O; Cutting B; Smiesko M; Jenal U; Ernst B; Trampuz A
    J Microbiol Methods; 2010 Sep; 82(3):249-55. PubMed ID: 20620174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation-The Example of FimH.
    Krammer EM; de Ruyck J; Roos G; Bouckaert J; Lensink MF
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29976867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections.
    Mydock-McGrane L; Cusumano Z; Han Z; Binkley J; Kostakioti M; Hannan T; Pinkner JS; Klein R; Kalas V; Crowley J; Rath NP; Hultgren SJ; Janetka JW
    J Med Chem; 2016 Oct; 59(20):9390-9408. PubMed ID: 27689912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
    Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for success.
    Jiang X; Abgottspon D; Kleeb S; Rabbani S; Scharenberg M; Wittwer M; Haug M; Schwardt O; Ernst B
    J Med Chem; 2012 May; 55(10):4700-13. PubMed ID: 22519985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
    Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
    J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofilm formation by multidrug resistant Escherichia coli ST131 is dependent on type 1 fimbriae and assay conditions.
    Sarkar S; Vagenas D; Schembri MA; Totsika M
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased tracheal colonization in chickens without impairing pathogenic properties of avian pathogenic Escherichia coli MT78 with a fimH deletion.
    Arné P; Marc D; Brée A; Schouler C; Dho-Moulin M
    Avian Dis; 2000; 44(2):343-55. PubMed ID: 10879915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannosylated N-aryl substituted 3-hydroxypyridine-4-ones: synthesis, hemagglutination inhibitory properties, and molecular modeling.
    Car Z; Hrenar T; Petrović Peroković V; Ribić R; Seničar M; Tomić S
    Chem Biol Drug Des; 2014 Oct; 84(4):393-401. PubMed ID: 24674669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tyrosine gate of the bacterial lectin FimH: a conformational analysis by NMR spectroscopy and X-ray crystallography.
    Fiege B; Rabbani S; Preston RC; Jakob RP; Zihlmann P; Schwardt O; Jiang X; Maier T; Ernst B
    Chembiochem; 2015 May; 16(8):1235-46. PubMed ID: 25940742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FimH antagonists: structure-activity and structure-property relationships for biphenyl α-D-mannopyranosides.
    Pang L; Kleeb S; Lemme K; Rabbani S; Scharenberg M; Zalewski A; Schädler F; Schwardt O; Ernst B
    ChemMedChem; 2012 Aug; 7(8):1404-22. PubMed ID: 22644941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.